Navigation Links
The Outlook for Pharmaceuticals in Western Europe
Date:3/6/2012

h rates twice this figure in recent years, although growth rates are now falling due to greater regulatory controls in this sector and fewer innovative drugs coming to market. The underdeveloped generics market is undergoing rapid expansion, boosted by government incentives and the loss of patent protection for several high-volume products. The stagnating OTC market has also started to expand, as a result of government moves to end reimbursement for a wide range of products assigned a low medical value rating.

GERMANY

Germany's economy depends heavily on exports and was therefore hit hard by the global downturn. However, GDP is expected to strengthen over the next five years. The German pharmaceutical market is the largest in Europe. Growth in recent years has tended to be uneven, as government reforms take effect on pricing and/or reimbursement. A new law passed in November 2010, designed to bring down the average price of drugs, is expected to dampen growth slightly over the next few years. The pharmaceutical market is projected to increase at a low CAGR between 2011 and 2016. The law reduces the power that pharmaceutical companies have in deciding what to charge for new prescription drugs. New, innovative drugs have been targeted as they were entirely responsible for the increase in drug spending in 2009. The German biotechnology market is expanding; biopharmaceuticals are expected to represent a fifth of the overall pharmaceutical market by 2020, according to Sandoz.

ITALY

The size of the population and the provision of universal healthcare under the national health service ensures that the Italian pharmaceutical market remains the third largest in Europe despite the market having the lowest growth rate of all the developed economies. The Italian population is ageing and the percentage over 65 years has already exceeded 20% and is set to rise still further with a corresponding increase in chronic and long-term medical conditions. Thi
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Branded Prescription Pharmaceutical Sales Outlook to 2016 - Sales to Rise by Just $29bn by 2016
2. Hill-Rom Reports Fiscal First Quarter Results; Provides Second Quarter and Full Year Financial Outlook
3. Ampio Pharmaceuticals Schedules 2012 Outlook Webcast
4. The Market Outlook for Refurbished Medical Devices to 2016
5. Global Diagnostic Imaging Market Trends and Outlook
6. Airway and Anesthesia Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017
7. E7: The Outlook for Pharmaceuticals to 2012
8. Hill-Rom Announces Preliminary Fiscal First Quarter Financial Results; Updates 2012 Financial Outlook
9. The Outlook for Medical Devices Worldwide
10. Magnetic Resonance Imaging (MRI) Systems Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017
11. The Outlook for Pharmaceuticals Worldwide
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... 28, 2014  A prospective study conducted by ... has validated the performance of VolparaDensity breast ... associated volumetrically assessed breast density measurements to breast ... & Prevention (DOI: 10.1158/1055-9965.EPI-13-1219), the article, "Automated ... widespread breast cancer risk assessment," was authored by ...
(Date:7/28/2014)... -- Houston dentist , Dr. Behzad Nazari ... Invisalign. With access to this increasingly popular orthodontic ... without feeling self-conscious in the process. Invisalign offers ... of braces, but patients who choose Invisalign over ... support for their oral health and comfort during ...
(Date:7/28/2014)... ORLANDO, Fla. , July 28, 2014 /PRNewswire/ ... "Company"), a biopharmaceutical company focused on the development, ... that it has filed definitive proxy materials with ... its 2014 Annual Meeting of Shareholders to be ... a.m., East Standard Time. The record date for ...
Breaking Medicine Technology:Karolinska Study Published in Cancer Epidemiology, Biomarkers & Prevention Validates Strong Agreement for VolparaDensity across Mammography Systems from Multiple Manufacturers 2Karolinska Study Published in Cancer Epidemiology, Biomarkers & Prevention Validates Strong Agreement for VolparaDensity across Mammography Systems from Multiple Manufacturers 3Karolinska Study Published in Cancer Epidemiology, Biomarkers & Prevention Validates Strong Agreement for VolparaDensity across Mammography Systems from Multiple Manufacturers 4Houston Cosmetic Dentist, Dr. Behzad Nazari, Now Offers Orthodontic Treatment with Invisalign 2TNI BioTech, Inc., Files Definitive Proxy Materials; Mails Letter Urging Shareholders to Vote the Proxy Card 2TNI BioTech, Inc., Files Definitive Proxy Materials; Mails Letter Urging Shareholders to Vote the Proxy Card 3
... Calif., June 04, 2007 /PRNewswire-FirstCall/ -- Kosan,Biosciences ... clinical,trial showing that KOS-1584/R1645, an epothilone under,co-development ... in patients with solid tumors.,KOS-1584/R1645 showed activity ... including activity in patients with non-small cell ...
... Investigational cancer drug Pertuzumab shows promising results ... Phase III,development initiated, BASEL, Switzerland, June 4, ... exciting new cancer medicine pertuzumab, a HER,dimerisation ... pre-treated HER2 positive breast cancer, when,combined with ...
Cached Medicine Technology:Kosan Presents Phase 1 Data Showing Promising Antitumor Activity,and Safety Profile of Epothilone KOS-1584 at ASCO 2Kosan Presents Phase 1 Data Showing Promising Antitumor Activity,and Safety Profile of Epothilone KOS-1584 at ASCO 3Kosan Presents Phase 1 Data Showing Promising Antitumor Activity,and Safety Profile of Epothilone KOS-1584 at ASCO 4Kosan Presents Phase 1 Data Showing Promising Antitumor Activity,and Safety Profile of Epothilone KOS-1584 at ASCO 5Investigational Cancer Drug Pertuzumab Shows Promising Results in,Advanced Breast Cancer When Combined with Herceptin 2Investigational Cancer Drug Pertuzumab Shows Promising Results in,Advanced Breast Cancer When Combined with Herceptin 3Investigational Cancer Drug Pertuzumab Shows Promising Results in,Advanced Breast Cancer When Combined with Herceptin 4Investigational Cancer Drug Pertuzumab Shows Promising Results in,Advanced Breast Cancer When Combined with Herceptin 5
(Date:7/28/2014)... New York, NY (PRWEB) July 28, 2014 ... tickets for the Guinness International Champions Cup Match between ... new Yankee Stadium in the Bronx has hosted countless big ... have the charm and history of the original Yankee Stadium, ... events in the New York City metro area. , ...
(Date:7/28/2014)... Scottsdale, Ariz (PRWEB) July 28, 2014 ... closed on a new camp property in Cornville, ... provides seriously ill children with the opportunity to ... the campers and families. The organization offers a ... ages 6-15 with chronic and life threatening illnesses ...
(Date:7/28/2014)... Quincy Bioscience, makers of the nation’s leading memory ... release of the fourth edition of The Brain Health ... , The Brain Health Guide is a unique resource ... to improve memory and promote optimal aging. Rather than ... Guide provides ways to help minimize common memory lapses ...
(Date:7/28/2014)... Randy Dotinga HealthDay Reporter ... takes humans just milliseconds to look at someone,s face and ... study finds that certain facial features seem to trigger specific ... and size of the mouth, for example, appear directly linked ... to attractiveness. The study findings suggest that first ...
(Date:7/28/2014)... Ticket Down is reliable source ... Dallas, TX at the Cotton Bowl. The 2014 Guinness ... and it is an eight team tourney. The tournament ... teams from La Liga, Serie A, English Premier League, and ... out on the pitch include: Manchester United, Manchester City, ...
Breaking Medicine News(10 mins):Health News:Liverpool FC vs. Manchester City Tickets at Yankee Stadium: Ticket Down Reports Huge Demand for Guinness International Champions Cup Tickets in NYC 2Health News:Liverpool FC vs. Manchester City Tickets at Yankee Stadium: Ticket Down Reports Huge Demand for Guinness International Champions Cup Tickets in NYC 3Health News:Camp Soaring Eagle Announces New Camp Site 2Health News:Camp Soaring Eagle Announces New Camp Site 3Health News:Quincy Bioscience Launches the Fourth Edition of The Brain Health Guide 2Health News:Facial Dimensions May Be Key to First Impressions 2Health News:Facial Dimensions May Be Key to First Impressions 3Health News:Real Madrid vs. AS Roma Tickets Cotton Bowl Dallas, TX: Ticket Down Cuts Ticket Prices for AS Roma vs. Real Madrid International Champions Cup Tickets 2Health News:Real Madrid vs. AS Roma Tickets Cotton Bowl Dallas, TX: Ticket Down Cuts Ticket Prices for AS Roma vs. Real Madrid International Champions Cup Tickets 3
... Products from AnaSpec, Accelrys, Almac Diagnostics, Seahorse Biosciences, BioFortis recognized ... ... San Francisco, CA (PRWEB) March 3, 2009 ... biotech companies that have won the Third Annual Best ...
... American Journal of Epidemiology , Oregon Research Institute ... a high-density of fast food outlets was associated with ... inches in waist circumference among neighborhood residents who frequently ... associated with a decrease of 2.7 pounds in weight ...
... types of child maltreatment are robust risk factors for ... that explored the influence of social environment on the ... appears in the current issue of Addictive Behaviors ... more alcoholic drinks on a single occasion at least ...
... 3 TouchMark, a division of Delphon Industries and industry ... is offering complimentary NRE (Non-Recurring Engineering or set-up fees) on ... customer who submits a new Pad Print order will not ... our customers, loyalty to TouchMark," says Jeanne Beacham, CEO. ...
... BOSTON, March 3 Important deadlines are approaching ... settlement related to the average wholesale prices of ... for the District of Massachusetts granted preliminary approval ... In the lawsuit, In re: Pharmaceutical Industry ...
... 3 Rochester Medical Corporation (Nasdaq: ROCM ... the company,s outstanding common shares pursuant to its previously ... repurchase shares from time to time on the open ... accordance with applicable SEC guidelines and regulations. Additionally, the ...
Cached Medicine News:Health News:Best New Product Awards Winners Named at Molecular Medicine Tri-Conference 2Health News:Best New Product Awards Winners Named at Molecular Medicine Tri-Conference 3Health News:Fast-food density and neighborhood walkability affect residents' weight and waist size 2Health News:How multiple childhood maltreatments lead to greater adolescent binge drinking 2Health News:How multiple childhood maltreatments lead to greater adolescent binge drinking 3Health News:Important Deadlines Near for $21 Million Class Action Settlement That Provides Consumers With Money Back for Over 200 Prescription Drugs 2Health News:Rochester Medical Renews Share Repurchase Activity 2
...
... FLEXILOG antimony pH catheters are designed for patient ... ,All catheters are number marked at 5cm intervals ... than sixteen individual models are available spanning most ... or multi-use models with one or two sensors., ...
... The Standard VersaFlex™ disposable pH ... nurses, and clinics worldwide for evaluating ... catheters for 24-hour esophageal pH monitoring. ... the smallest diameter esophageal catheter on ...
FLEXILOG accessory....
Medicine Products: